Log in

Relevant bibliographies by topics / EUlaw / Journal articles

To see the other types of publications on this topic, follow the link: EUlaw.

Journal articles on the topic 'EUlaw'

Author: Grafiati

Published: 10 March 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'EUlaw.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Grosse, Tomasz Grzegorz. "Low Carbon Economy Policy in Poland: an Example of the Impact of Europeanisation." Equilibrium 6, no. 1 (March 31, 2011): 9–39. http://dx.doi.org/10.12775/equil2011.001.

Full text

Abstract:

Poland has made a commitment to reduce the emission of greenhouse gases by ratifying the Kyoto Protocol and by participating in the climate policy of the European Union (EU). EUClimate and Energy Package (CEP), which was negotiated in 2008 and has been successively introduced into the EUlegal system. The CEP introduces much stricter requirements for the reduction of greenhouse gases emissions and imposes higher costs on the adjustment of Polish energy sector and other sectors of Polish economy to the requirements of the EUlaw. The influence of the EUon the Member States during the course of European integration is described in the literature of the subject as europeanisation. In this study Iwill analyse the influence on the policy of the Polish government with respect to stimulating the development of low carbon economy (including industry).

APA, Harvard, Vancouver, ISO, and other styles

2

Torres-Hostench, Olga, Ramon Piqué Huerta, and Pilar Cid Leal. "Decision-making in the translation of end-user license agreements." Culture & Society issue 4, no. 2 (December 31, 2015): 216–39. http://dx.doi.org/10.1075/ts.4.2.03tor.

Full text

Abstract:

EULAs (End-User License Agreements) present specific translation challenges, ones contingent on how the EULAs will be used. In a recent study, the decisions made by forty-seven translation students while translating a EULA were observed and analyzed. The aim of the study was threefold: (1) to observe the criteria used for decision-making when translating a EULA; (2) to observe how decision-making criteria changed after using specific resources designed for translating EULAs (lawcalisation.com); and (3) to evaluate the overall usefulness of the lawcalisation.com resource. Results suggest that by providing translators with a single website portal of specific resources, they were able not only to find the equivalents they needed but also to consult the relevant legal and translation information that ultimately helped them develop more solid criteria for translation decision-making. Decisions were guided by principles of law applicability, terminology, legislation, and translation studies Skopos theories.

APA, Harvard, Vancouver, ISO, and other styles

3

Brooks, Helen, Anna Clark, and Heather Van Epps. "EULAR 2021." Lancet Rheumatology 3, no. 8 (August 2021): e551-e552. http://dx.doi.org/10.1016/s2665-9913(21)00228-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Lengerken, Hanns v. "Eulan M." Zeitschrift für Angewandte Entomologie 10, no. 2 (August 26, 2009): 472–76. http://dx.doi.org/10.1111/j.1439-0418.1924.tb01547.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Gross, W. L., and F. Moosig. "EULAR-Recommandations." Zeitschrift für Rheumatologie 67, no. 8 (November 16, 2008): 703. http://dx.doi.org/10.1007/s00393-008-0367-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Bach, Bianca. "EULAR Kongress-Splitter." Orthopädie & Rheuma 24, no. 4 (August 2021): 18. http://dx.doi.org/10.1007/s15002-021-3309-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Musa, Sanjin. "On immunity: an inoculation, Eula Biss." Central European Journal of Paediatrics 13, no. 1 (March 15, 2017): 81–83. http://dx.doi.org/10.5457/p2005-114.175.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

van Onna, Marloes, Sofia Ramiro, Catherine Haines, Mette Holland-Fischer, Jose Antonio Pereira da Silva, Jean Dudler, Chris Edwards, et al. "EULAR portfolio for Rheumatology training: a EULAR School of Rheumatology initiative." RMD Open 7, no. 2 (June 2021): e001684. http://dx.doi.org/10.1136/rmdopen-2021-001684.

Full text

Abstract:

ObjectiveAbout half of the rheumatology trainees do not use a portfolio. This project was established to reach consensus about the content of a EULAR portfolio for Rheumatology training and subsequently develop portfolio assessment forms.MethodsAfter establishing a portfolio working group (WG), including nine rheumatologists and one educationalist, a systematic literature review (SLR) on the content and structure of portfolios for postgraduate learning was conducted (November 2018). This was followed by a survey among WG members and members of the EMerging EUlar NETwork, inquiring about the content and structure of existing national portfolios. The portfolio WG selected the key components of the portfolio, taking previous experience and feasibility into account. Assessment forms (eg, case-based discussion) were developed and pilot-tested.Results13/2034 articles were included in the SLR (12 high/1 moderate risk of bias). Information on procedural skills, personal reflections, learning goals and multisource feedback was most often included a portfolio. Twenty-five respondents completed the survey (response≈50%). Feedback from assessors, reflective writing and formulation of learning goals were considered important dimensions to be covered in a portfolio. Six key components of the portfolio were established: curriculum vitae, personal development plan, clinical work, professional behaviours, education and research activities. Suggested minimal content for each component was formulated. Four assessment forms were successfully pilot-tested by 11 rheumatologists and their trainees.ConclusionA EULAR portfolio for Rheumatology training and assessment forms were developed. Portfolio implementation, particularly in countries without an existing portfolio, may promote a higher standard of rheumatology training across Europe.

APA, Harvard, Vancouver, ISO, and other styles

9

Rosa, Bogdan, Miłosz Ciżnicki, Krzysztof A. Rojek, Damian K. Wójcik, Piotr K. Smolarkiewicz, and Roman Wyrzykowski. "Porting Multiscale Fluid Model EULAG to Modern Heterogeneous Architectures." International Journal of Applied Physics and Mathematics 4, no. 3 (2014): 188–95. http://dx.doi.org/10.7763/ijapm.2014.v4.281.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Lunzer, Raimund. "Highlights vom EULAR 2021." Schmerz Nachrichten 21, no. 3 (August 14, 2021): 24–25. http://dx.doi.org/10.1007/s44180-021-0008-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Pascual Gomez, E. "SP0155 Eular Gout Treatment." Annals of the Rheumatic Diseases 73, Suppl 2 (June 2014): 41.4–42. http://dx.doi.org/10.1136/annrheumdis-2014-eular.6315.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

VAN DE PUTTE, L. B. A. "EULAR and its journal." Annals of the Rheumatic Diseases 60, no. 6 (June 1, 2001): 545. http://dx.doi.org/10.1136/ard.60.6.545.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

gvg and otc. "Das Wichtigste vom EULAR." CME 12, no. 7-8 (August 2015): 46. http://dx.doi.org/10.1007/s11298-015-1429-z.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Partridge, Alison J. "EULAR meeting, Athens, Greece." Arthritis Care & Research 1, no. 1 (March 1988): 60. http://dx.doi.org/10.1002/art.1790010114.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

van der Heijde, Désirée, Daniel Aletaha, Loreto Carmona, Christopher J. Edwards, Tore K. Kvien, Marios Kouloumas, Pedro Machado, Sue Oliver, Maarten de Wit, and Maxime Dougados. "2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations." Annals of the Rheumatic Diseases 74, no. 1 (September 26, 2014): 8–13. http://dx.doi.org/10.1136/annrheumdis-2014-206350.

Full text

Abstract:

In this article, the European League Against Rheumatism (EULAR) standardised operating procedures for the elaboration, evaluation, dissemination and implementation of recommendations endorsed by the EULAR standing committees published in 2004 have been updated. The various steps from the application to implementation have been described in detail.

APA, Harvard, Vancouver, ISO, and other styles

16

Ovseiko, P. V., L. Gossec, L. Andreoli, U. Kiltz, L. Van Mens, N. Hassan, M. Van der Leeden, et al. "OP0074 A FRAMEWORK OF POTENTIAL INTERVENTIONS TO ACCELERATE GENDER-EQUITABLE CAREER ADVANCEMENT IN ACADEMIC RHEUMATOLOGY." Annals of the Rheumatic Diseases 80, Suppl 1 (May 19, 2021): 39.1–40. http://dx.doi.org/10.1136/annrheumdis-2021-eular.1765.

Full text

Abstract:

Background:A growing number of professional societies in clinical and medically related disciplines investigate evidence, make recommendations, and take action to advance gender equity. Evidence on women’s advancement and leadership in the context of the European Alliance of Associations for Rheumatology, EULAR, is limited [1].Objectives:The objective of the EULAR Task Force on Gender Equity in Academic Rheumatology was to establish the extent of the unmet need for support of female rheumatologists, health professionals and non-clinical scientists in academic rheumatology and develop a framework to address this through EULAR and Emerging EULAR Network (EMEUNET).Methods:Potential interventions to accelerate gender-equitable career advancement in academic rheumatology were gathered from a narrative review of the relevant literature, expert opinion of a multi-disciplinary Task Force (comprised of 23 members from 11 countries), data from the surveys of EULAR scientific member society leaders, EULAR and EMEUNET members, and EULAR Executive Committee members. These interventions were rated by Task Force members, who ranked each according to perceived priority on a five-point numeric scale from 1 = very low to 5 = very high.Results:A framework of 29 potential interventions was formulated, which covers six thematic areas, namely, EULAR policies, advocacy and communication, EULAR Congress and associated symposia, training courses, mentoring/peer support, and EULAR funding (Figure 1).Figure 1.A framework of potential interventions with the levels of priority, mean and standard deviation (SD)Conclusion:The framework provides structured interventions for accelerating gender-equitable career advancement in academic rheumatology.References:[1]Andreoli L, Ovseiko PV, Hassan N, et al. Gender equity in clinical practice, research and training: Where do we stand in rheumatology? Joint Bone Spine 2019;86(6):669-72.Acknowledgements:The task force is grateful to EULAR for funding this activity under project number EPI 024.Disclosure of Interests:None declared

APA, Harvard, Vancouver, ISO, and other styles

17

Moskalewicz, Bożena, and Jolanta Grygielska. "EULAR PARE: Knowledge Transfer Programme." Reumatologia/Rheumatology 58, no. 2 (2020): 123–25. http://dx.doi.org/10.5114/reum.2020.95367.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

&NA;. "Focus on biologicals at EULAR." Reactions Weekly &NA;, no. 1308 (July 2010): 4. http://dx.doi.org/10.2165/00128415-201013080-00008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Van Nieuwkoop, L. "SP0190 EULAR Pare Youth Strategy." Annals of the Rheumatic Diseases 74, Suppl 2 (June 2015): 46.1–46. http://dx.doi.org/10.1136/annrheumdis-2015-eular.6632.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Vinall, M., and M. Dougados. "Interview with the EULAR President." MD Conference Express 12, no. 9 (August 1, 2012): 6. http://dx.doi.org/10.1177/155989771209002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

DIEPPE, P. "An evidence based EULAR meeting?" Annals of the Rheumatic Diseases 59, no. 4 (April 1, 2000): 319a—319. http://dx.doi.org/10.1136/ard.59.4.319a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

VAN DE PUTTE, L. B. A. "The first annual EULAR Congress." Annals of the Rheumatic Diseases 59, no. 6 (June 1, 2000): 401. http://dx.doi.org/10.1136/ard.59.6.401.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

WALSH, NANCY. "EULAR Issues Fibromyalgia Treatment Guidelines." Rheumatology News 6, no. 10 (October 2007): 18. http://dx.doi.org/10.1016/s1541-9800(07)70568-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Kathmann, Wiebke. "EULAR-Leitlinie zur intraartikulären Therapie." Orthopädie & Rheuma 23, no. 4 (August 2020): 16–17. http://dx.doi.org/10.1007/s15002-020-2892-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Mayor, Susan. "EULAR updates rheumatoid arthritis guidelines." British Journal of Hospital Medicine 74, no. 8 (August 2013): 430. http://dx.doi.org/10.12968/hmed.2013.74.8.430.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Lunzer, R., and T. Nothnagl. "Eular 2020: Kurzer Überblick – Praxisrelevant …!" rheuma plus 19, no. 5 (September 9, 2020): 190–93. http://dx.doi.org/10.1007/s12688-020-00367-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Mucke, J., and J. Leipe. "EMEUNET – Das EMerging EUlar NETwork." Zeitschrift für Rheumatologie 77, no. 1 (December 12, 2017): 7–9. http://dx.doi.org/10.1007/s00393-017-0411-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Edwards, Christopher J. "Free educational material on the EULAR school of rheumatology website." RMD Open 8, no. 2 (November 2022): e002765. http://dx.doi.org/10.1136/rmdopen-2022-002765.

Full text

Abstract:

There is lots of educational content including free educational material for all those interested in rheumatic and musculoskeletal diseases (RMDs) on the EULAR School of Rheumatology (ESOR) website. It’s easy to access and just three clicks can take you straight to the content you need. Search for ESOR in your web browser (1), click on ‘catalog’, click on ‘free learning material’. Choose what you need, one more click, and you’re there. In particular, the EULAR imaging library and EULAR learning material for RA will give you lots of images and slides to help with your presentations. EULAR has a long history of providing education for rheumatologists, health professionals in rheumatology and people with RMDs. This commitment to education is enshrined in the EULAR strategy and will always be a large part of what EULAR does.

APA, Harvard, Vancouver, ISO, and other styles

29

Ovseiko, Pavel V., Laure Gossec, Laura Andreoli, Uta Kiltz, Leonieke van Mens, Neelam Hassan, Marike van der Leeden, et al. "Gender equity in academic rheumatology, current status and potential for improvement: a cross-sectional study to inform an EULAR task force." RMD Open 8, no. 2 (August 2022): e002518. http://dx.doi.org/10.1136/rmdopen-2022-002518.

Full text

Abstract:

ObjectivesEvidence on the current status of gender equity in academic rheumatology in Europe and potential for its improvement is limited. The EULAR convened a task force to obtain empirical evidence on the potential unmet need for support of female rheumatologists, health professionals and non-clinical scientists in academic rheumatology.MethodsThis cross-sectional study comprised three web-based surveys conducted in 2020 among: (1) EULAR scientific member society leaders, (2) EULAR and Emerging EULAR Network (EMEUNET) members and (3) EULAR Council members. Statistics were descriptive with significance testing for male/female responses assessed by χ2 test and t-test.ResultsData from EULAR scientific member societies in 13 countries indicated that there were disproportionately fewer women in academic rheumatology than in clinical rheumatology, and they tended to be under-represented in senior academic roles. From 324 responses of EULAR and EMEUNET members (24 countries), we detected no gender differences in leadership aspirations, self-efficacy in career advancement and work–life integration as well as the share of time spent on research, but there were gender differences in working hours and the levels of perceived gender discrimination and sexual harassment. There were gender differences in the ranking of 7 of 26 factors impacting career advancement and of 8 of 24 potential interventions to aid career advancement.ConclusionsThere are gender differences in career advancement in academic rheumatology. The study informs a EULAR task force developing a framework of potential interventions to accelerate gender-equitable career advancement in academic rheumatology.

APA, Harvard, Vancouver, ISO, and other styles

30

Hassan, Neelam, Leonieke JJ van Mens, Uta Kiltz, Laura Andreoli, Concha Delgado-Beltran, Pavel V. Ovseiko, Laure Gossec, and Laura C. Coates. "Gender equity in academic rheumatology: is there a gender gap at European rheumatology conferences?" RMD Open 8, no. 1 (March 2022): e002131. http://dx.doi.org/10.1136/rmdopen-2021-002131.

Full text

Abstract:

ObjectivesTo obtain an overview of gender equity at European rheumatology conferences.MethodsThe proportion of women invited as either moderators or speakers to the European Alliance of Associations for Rheumatology (EULAR) annual congresses and national conferences in Europe was calculated from the published congress materials from EULAR annual congresses (2015–2019) and the 2019 national conferences of France, Germany, Italy, Spain and the UK. Data from EULAR congresses were further categorised by type of session. Significance testing was conducted using χ2 tests with the level of statistical significance set at p<0.05.ResultsThe proportion of combined women moderators and speakers at EULAR varied from 40% to 43% between 2015 and 2019 with no obvious trend over time. There were higher proportions of women in the Health Professionals in Rheumatology and People with Arthritis and Rheumatism sessions (>50% consistently). However, these sessions represent <25% of EULAR congress invitations. Representation of women at the EULAR congress in 2019 (39.6%) was significantly higher than at the national congresses in France (28.6%) and Germany (29.6%) but similar to that observed in Italy (33.7%), Spain (41.7%) and the UK (42%).ConclusionWomen account for less than half of invited moderators and speakers at the conferences reviewed. Compared with historical EULAR data in 2003 (16%) and in 2004 (19%), the gender gap at EULAR congresses has narrowed considerably, but there remains a need to monitor and improve women’s representation.

APA, Harvard, Vancouver, ISO, and other styles

31

MASRI, KARIM R., TIMOTHY S. SHAVER, SHADI H. SHAHOURI, SHIRLEY WANG, JAMES D. ANDERSON, RUTH E. BUSCH, KALEB MICHAUD, TED R. MIKULS, LIRON CAPLAN, and FREDERICK WOLFE. "Validity and Reliability Problems with Patient Global as a Component of the ACR/EULAR Remission Criteria as Used in Clinical Practice." Journal of Rheumatology 39, no. 6 (May 15, 2012): 1139–45. http://dx.doi.org/10.3899/jrheum.111543.

Full text

Abstract:

Objective.To investigate what factors influence patient global health assessment (PtGlobal), and how those factors and the reliability of PtGlobal affect the rate, reliability, and validity of recently published American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) rheumatoid arthritis (RA) remission criteria when used in clinical practice.Methods.We examined consecutive patients with RA in clinical practice and identified 77 who met ACR/EULAR joint criteria for remission (≤ 1 swollen joint and ≤ 1 tender joint). We evaluated factors associated with a PtGlobal > 1, because a PtGlobal ≤ 1 defined ACR/EULAR remission in this group of patients who had already met ACR/EULAR joint criteria.Results.Of the 77 patients examined, only 17 (22.1%) had PtGlobal ≤ 1 and thus fully satisfied ACR/EULAR criteria. A large proportion of patients not in remission by ACR/EULAR criteria had high PtGlobal related to noninflammatory issues, including low back pain, fatigue, and functional limitations, and a number of patients clustered in the range of PtGlobal > 1 and ≤ 2. However, the minimal detectable difference for PtGlobal was 2.3. In addition, compared with a PtGlobal severity score, a PtGlobal activity score was 3.3% less likely to be abnormal (> 1).Conclusion.Noninflammatory factors contribute to the level of PtGlobal and result in the exclusion of many patients who would otherwise be in “true” remission according to the ACR/EULAR definition. Reliability problems associated with PtGlobal can also result in misclassification, and may explain the observation of low longterm remission rates in RA. As currently constituted, the use of the ACR/EULAR remission criteria in clinical practice appears to be problematic.

APA, Harvard, Vancouver, ISO, and other styles

32

Mok, C. C., Y. K. Chung, C. Lee, L. Y. Ho, and C. H. To. "POS0771 VALIDATION OF THE 2019 EUROPEAN LEAGUE AGAINST RHEUMATISM/AMERICAN COLLEGE OF RHEUMATOLOGY (EULAR/ACR) CLASSIFICATION CRITERIA FOR SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) IN HONG KONG CHINESE." Annals of the Rheumatic Diseases 80, Suppl 1 (May 19, 2021): 639.2–640. http://dx.doi.org/10.1136/annrheumdis-2021-eular.3394.

Full text

Abstract:

Objectives:To validate the 2019 EULAR/ACR classification criteria for SLE in Hong Kong Chinese patients and compare its performance with the 2012 Systemic Lupus International Collaborating Clinics (SLICC) and 1997 American college of rheumatology (ACR) criteria.Methods:We retrospectively reviewed the medical records of consecutive patients who attended the Rheumatology clinics in Tuen Mun and Pok Oi hospitals between May and September 2019. Patients with anti-nuclear antibody (ANA) ≥1:80 were included and patients with ANA <1:80 or no ANA results were excluded. Patients were evaluated and cross-checked for the fulfilment of the 1997 ACR, 2012 SLICC and 2019 EULAR/ACR criteria by two investigators (YKC,CL). Medical records were then reviewed by an expert panel consisting of 3 senior rheumatologists, who were blinded for the results of the criteria evaluation, for a diagnosis of SLE based on the clinical judgement and therapeutic decisions. Teleconferences were arranged by the panel to discuss the discrepancies of the final diagnosis and agreement was made by voting. The three SLE criteria were evaluated against the clinical diagnosis of SLE as judged by the expert panel on the sensitivity and specificity, which was calculated by 2x2 contingency tables (“condition positive” = clinical diagnosis of SLE; “test positive” = criteria positive for SLE) with standard formulas (sensitivity = true positive/[true positive + false negative]; specificity = true negative / [true negative + false positive]). Receiver operating characteristic (ROC) curve was used to study the optimal cut-off points from the EULAR/ACR criteria for the highest summation of specificity and sensitivity.Results:3967 patients were screened; 1542 patients who were positive for ANA (≥1:80) were included (88.3% women). The mean age of these patients at first rheumatology clinic attendance was 45.6±15.0 years and the duration of follow-up was 7.5±7.0 years. A total of 567 patients were judged to have SLE by the expert panel (discrepancy of clinical diagnosis in 135 patients resolved with voting). The sensitivity and specificity of the three SLE classification criteria in our patients are listed in Table 1. ROC analysis showed that the best cut-off for a clinical diagnosis of SLE using the EULAR/ACR criteria was 10 points (area under the curve [AUC] 0.977; sensitivity 89.2% and specificity 89.6%). Similar figures were obtained for subgroups of patients stratified by gender and different age ranges.Conclusion:In our cohort of Hong Kong Chinese patients, the 2019 EULAR/ACR criteria is more sensitive but less specific when compared with 1997 ACR criteria for classifying SLE. On the other hand, the EULAR/ACR criteria is less sensitive but more specific than the 2012 SLICC criteria. The specificity of the EULAR/ACR criteria for SLE is higher in male than female patients. In our patients older than 50 years, the EULAR/ACR criteria is less sensitive but more specific for a classification of SLE. Overall, the performance of the EULAR/ACR criteria for a diagnosis of SLE in our study is similar to that reported in recent Asian studies although the sensitivity is lower, which may be related to the inclusion of ANA+ patients only.References:Classification criteriaSensitivitySpecificity1997 ACR85.9%94.4%2012 SLICC97.5%86.4%2019 EULAR/ACR with 10 points as cut-off89.2%89.6%2019 EULAR/ACR with 9 points as cut-off93.6%68.7%2019 EULAR/ACR with 11 points as cut-off86.9%92.4%2019 EULAR/ACR with 10 points as cut-off (men)88.9%94.5%2019 EULAR/ACR with 10 points as cut-off (women)89.2%88.8%2019 EULAR/ACR with 10 points as cut-off (age >50 years)78.7%94.1%2019 EULAR/ACR with 10 points as cut-off (age ≤50 years)91.7%84.1%Disclosure of Interests:None declared

APA, Harvard, Vancouver, ISO, and other styles

33

Uson, Jacqueline, Sebastián Cruz Rodriguez-García, Raul Castellanos-Moreira, Terence W. O'Neill, Michael Doherty, Mikael Boesen, Hemant Pandit, et al. "EULAR recommendations for intra-articular therapies." Annals of the Rheumatic Diseases 80, no. 10 (May 25, 2021): 1299–305. http://dx.doi.org/10.1136/annrheumdis-2021-220266.

Full text

Abstract:

ObjectivesTo establish evidence-based recommendations to guide health professionals using intra-articular therapies (IAT) in adult patients with peripheral arthropathies.MethodsA multidisciplinary international task force established the objectives, users and scope and the need for background information, including systematic literature reviews) and two surveys addressed to healthcare providers and patients throughout Europe. The evidence was discussed in a face-to-face meeting, recommendations were formulated and subsequently voted for anonymously in a three-round Delphi process to obtain the final agreement. The level of evidence was assigned to each recommendation with the Oxford levels of evidence.ResultsRecommendations focus on practical aspects to guide health professionals before, during and after IAT in adult patients with peripheral arthropathies. Five overarching principles and 11 recommendations were established, addressing issues related to patient information, procedure and setting, accuracy, routine and special aseptic care, safety issues and precautions to be addressed in special populations, efficacy and safety of repeated joint injections, use of local anaesthetics and aftercare.ConclusionWe have developed the first evidence and expert opinion-based recommendations to guide health professionals using IAT. We hope that these recommendations will be included in different educational programmes, used by patient associations and put into practice via scientific societies to help improve uniformity and quality of care when performing IAT in peripheral adult joints.

APA, Harvard, Vancouver, ISO, and other styles

34

Van Epps, Heather. "A call for papers: EULAR 2021." Lancet Rheumatology 3, no. 3 (March 2021): e170. http://dx.doi.org/10.1016/s2665-9913(21)00040-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

&NA;. "Adherence to EULAR recommendations falls short." Inpharma Weekly &NA;, no. 1477 (March 2005): 8. http://dx.doi.org/10.2165/00128413-200514770-00020.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Bijlsma, J. W. J., and R. Buff. "EULAR online course on rheumatic diseases." Annals of the Rheumatic Diseases 66, no. 1 (June 30, 2006): 128–29. http://dx.doi.org/10.1136/ard.2006.065334.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Macfarlane, Gary J., Caroline Kronisch, Fabiola Atzeni, Winfried Häuser, Ernest H. Choy, Kirstine Amris, Jaime Branco, et al. "EULAR recommendations for management of fibromyalgia." Annals of the Rheumatic Diseases 76, no. 12 (May 5, 2017): e54-e54. http://dx.doi.org/10.1136/annrheumdis-2017-211587.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Onuora, Sarah. "EULAR updates its RA management recommendations." Nature Reviews Rheumatology 16, no. 3 (January 30, 2020): 128. http://dx.doi.org/10.1038/s41584-020-0385-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Rizzo, T., and G. Bertsias. "EULAR/ERA-EDTA Lupus Nephritis Recommendations." MD Conference Express 12, no. 9 (August 1, 2012): 30. http://dx.doi.org/10.1177/155989771209024.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Vinall, M., and F. H. J. van den Hoogen. "2013 ACR-EULAR Scleroderma Classification Criteria." MD Conference Express 13, no. 18 (January 1, 2013): 12–13. http://dx.doi.org/10.1177/155989771318003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

GARE, B. A. "EULAR Standing Committee on Paediatric Rheumatology." Annals of the Rheumatic Diseases 60, no. 11 (November 1, 2001): 1014–15. http://dx.doi.org/10.1136/ard.60.11.1014.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Davergne, Thomas. "EULAR 2018 et événement à venir." Kinésithérapie, la Revue 18, no. 204 (December 2018): 79–81. http://dx.doi.org/10.1016/j.kine.2018.09.003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

TUCKER, MIRIAM E. "ACR/EULAR Criteria Define RA Remission." Rheumatology News 10, no. 3 (March 2011): 27. http://dx.doi.org/10.1016/s1541-9800(11)70176-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

FREEMAN, SARA. "ACR/EULAR Arthritis Criteria Risk Overdiagnosis." Rheumatology News 10, no. 6 (June 2011): 2. http://dx.doi.org/10.1016/s1541-9800(11)70362-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

NAPOLI, DENISE. "EULAR Standardizes Nurses' Role in Arthritis." Rheumatology News 10, no. 6 (June 2011): 12. http://dx.doi.org/10.1016/s1541-9800(11)70370-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

da Silva, J. A. P. "VIIth EULAR Postgraduate Course in Rheumatology." Annals of the Rheumatic Diseases 62, no. 3 (March 1, 2003): 286. http://dx.doi.org/10.1136/ard.62.3.286.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Amor, B., P. Tovanen, H. M. Moutsopoulos, B. Sauvezie, P. Dieppe, A. Maroudas, P. Meunier, Ch Nagant de Deuxchaisnes, G. Panayi, and T. Vischer. "Sixth Eular Workshop on Rheumatology Research." Clinical Rheumatology 5, no. 1 (March 1986): 126–61. http://dx.doi.org/10.1007/bf02030982.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Fournier, C., B. Texier, G. Chiocchia, M. C. Boissier, D. Herbage, C. M. S. Brown, C. Plater Zyberk, et al. "IX Eular Workshop for Rheumatology Research." Clinical Rheumatology 8, no. 1 (March 1989): 118–72. http://dx.doi.org/10.1007/bf02031083.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Benamou, P. H. "European League Against Rheumatism 2012 (EULAR)." Médecine et Chirurgie du Pied 28, no. 3 (July 12, 2012): 75–82. http://dx.doi.org/10.1007/s10243-012-0344-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Aringer, Martin. "EULAR/ACR classification criteria for SLE." Seminars in Arthritis and Rheumatism 49, no. 3 (December 2019): S14—S17. http://dx.doi.org/10.1016/j.semarthrit.2019.09.009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!